Catharine Porter

Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial

Douglas Adamson, Anthony Byrne, Catharine Porter et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 50 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial

Dean A. Fennell, Catharine Porter, J.F. Lester et al. · EClinicalMedicine · 2022 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

A randomized phase II trial of oral vinorelbine as second-line therapy for patients with malignant pleural mesothelioma.

Dean A. Fennell, Angela Casbard, Catharine Porter et al. · Journal of Clinical Oncology · 2021 · 32 citations

Medicine, Pharmacology, Pharmacotherapy +14

Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial

Dean A. Fennell, Catharine Porter, J.F. Lester et al. · EClinicalMedicine · 2022 · 27 citations · Full text

Medicine, Oncology, Pharmacology +15